FGFR3 c.1108G>T ;(p.G370C)

Variant ID: 4-1806089-G-T

NM_000142.4(FGFR3):c.1108G>T;(p.G370C)

This variant was identified in 132 publications

View GRCh38 version.




Publications:


The Role of Biomarkers in Guiding Clinical Decision-Making in Oncology.

Journal Of The Advanced Practitioner In Oncology
Moore, Donald C DC; Guinigundo, Andrew S AS
Publication Date: 2023-04

Variant appearance in text: FGFR3: 1108G>T; G370C
PubMed Link: 37206905
Variant Present in the following documents:
  • Main text
  • jadpro-14-15.pdf
View BVdb publication page



Assessing variants of uncertain significance implicated in hearing loss using a comprehensive deafness proteome.

Human Genetics
Tollefson, Mallory R MR; Gogal, Rose A RA; Weaver, A Monique AM; Schaefer, Amanda M AM; Marini, Robert J RJ; Azaiez, Hela H; Kolbe, Diana L DL; Wang, Donghong D; Weaver, Amy E AE; Casavant, Thomas L TL; Braun, Terry A TA; Smith, Richard J H RJH; Schnieders, Michael J MJ
Publication Date: 2023-04-22

Variant appearance in text: FGFR3: 1108G>T; Gly370Cys
PubMed Link: 37086329
Variant Present in the following documents:
  • 439_2023_2559_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page



A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Jang, H Josh HJ; Hostetter, Galen G; MacFarlane, Alexander W AW; Madaj, Zachary Z; Ross, Eric A EA; Hinoue, Toshinori T; Kulchycki, Justin R JR; Burgos, Ryan S RS; Tafseer, Mahvish M; Alpaugh, R Katherine RK; Schwebel, Candice L CL; Kokate, Rutika R; Geynisman, Daniel M DM; Zibelman, Matthew R MR; Ghatalia, Pooja P; Nichols, Peter W PW; Chung, Woonbok W; Madzo, Jozef J; Hahn, Noah M NM; Quinn, David I DI; Issa, Jean-Pierre J JJ; Topper, Michael J MJ; Baylin, Stephen B SB; Shen, Hui H; Campbell, Kerry S KS; Jones, Peter A PA; Plimack, Elizabeth R ER
Publication Date: 2023-03-16

Variant appearance in text: FGFR3: G370C
PubMed Link: 36928921
Variant Present in the following documents:
  • ccr-22-3642_supplementary_tables_1_suppts1.xlsx, sheet 3
View BVdb publication page



Genomics-Driven Precision Medicine in Pediatric Solid Tumors.

Cancers
Suthapot, Praewa P; Chiangjong, Wararat W; Chaiyawat, Parunya P; Choochuen, Pongsakorn P; Pruksakorn, Dumnoensun D; Sangkhathat, Surasak S; Hongeng, Suradej S; Anurathapan, Usanarat U; Chutipongtanate, Somchai S
Publication Date: 2023-02-23

Variant appearance in text: FGFR3: G370C
PubMed Link: 36900212
Variant Present in the following documents:
  • Main text
  • cancers-15-01418.pdf
View BVdb publication page



Molecular-Targeted Therapy for Tumor-Agnostic Mutations in Acute Myeloid Leukemia.

Biomedicines
Arai, Hironori H; Minami, Yosuke Y; Chi, SungGi S; Utsu, Yoshikazu Y; Masuda, Shinichi S; Aotsuka, Nobuyuki N
Publication Date: 2022-11-22

Variant appearance in text: FGFR3: G370C
PubMed Link: 36551764
Variant Present in the following documents:
  • biomedicines-10-03008.pdf
View BVdb publication page



Landscape of the intratumroal microenvironment in bladder cancer: Implications for prognosis and immunotherapy.

Computational And Structural Biotechnology Journal
Bian, Zichen Z; Chen, Jia J; Liu, Chang C; Ge, Qintao Q; Zhang, Meng M; Meng, Jialin J; Liang, Chaozhao C
Publication Date: 2023

Variant appearance in text: FGFR3: G370C
PubMed Link: 36514337
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations.

Esmo Open
Murugesan, K K; Necchi, A A; Burn, T C TC; Gjoerup, O O; Greenstein, R R; Krook, M M; López, J A JA; Montesion, M M; Nimeiri, H H; Parikh, A R AR; Roychowdhury, S S; Schwemmers, S S; Silverman, I M IM; Vogel, A A
Publication Date: 2022-11-30

Variant appearance in text: FGFR3: G370C
PubMed Link: 36462464
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria.

American Journal Of Human Genetics
Pejaver, Vikas V; Byrne, Alicia B AB; Feng, Bing-Jian BJ; Pagel, Kymberleigh A KA; Mooney, Sean D SD; Karchin, Rachel R; O'Donnell-Luria, Anne A; Harrison, Steven M SM; Tavtigian, Sean V SV; Greenblatt, Marc S MS; Biesecker, Leslie G LG; Radivojac, Predrag P; Brenner, Steven E SE; ,
Publication Date: 2022-12-01

Variant appearance in text: rs121913479
PubMed Link: 36413997
Variant Present in the following documents:
  • mmc3.xlsx, sheet 1
View BVdb publication page



Somatic mutation distribution across tumour cohorts provides a signal for positive selection in cancer.

Nature Communications
Boström, Martin M; Larsson, Erik E
Publication Date: 2022-11-17

Variant appearance in text: FGFR3: G370C
PubMed Link: 36396655
Variant Present in the following documents:
  • 41467_2022_34746_MOESM10_ESM.xlsx, sheet 1
View BVdb publication page



FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1/3 mRNA Expression.

Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology
Sternberg, Cora N CN; Petrylak, Daniel P DP; Bellmunt, Joaquim J; Nishiyama, Hiroyuki H; Necchi, Andrea A; Gurney, Howard H; Lee, Jae-Lyun JL; van der Heijden, Michiel S MS; Rosenbaum, Eli E; Penel, Nicolas N; Pang, See-Tong ST; Li, Jian-Ri JR; García Del Muro, Xavier X; Joly, Florence F; Pápai, Zsuzsanna Z; Bao, Weichao W; Ellinghaus, Peter P; Lu, Chengxing C; Sierecki, Mitchell M; Coppieters, Sabine S; Nakajima, Keiko K; Ishida, Tatiane Cristine TC; Quinn, David I DI
Publication Date: 2022-10-14

Variant appearance in text: FGFR3: G370C
PubMed Link: 36240478
Variant Present in the following documents:
  • Main text
  • jco-41-629.pdf
View BVdb publication page



The mutational landscape of cancer's vulnerability to ionizing radiation.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Gopal, Priyanka P; Yard, Brian D BD; Petty, Aaron A; Lal, Jessica C JC; Bera, Titas K TK; Hoang, Trung Q TQ; Buhimschi, Alexandru B AB; Abazeed, Mohamed E ME
Publication Date: 2022-10-12

Variant appearance in text: FGFR3: G370C
PubMed Link: 36222846
Variant Present in the following documents:
  • ccr-22-1914_supplementary_data_3_suppds3.xlsx, sheet 1
  • ccr-22-1914_supplementary_data_2_suppds2.xlsx, sheet 1
View BVdb publication page



Clinical management and emerging therapies of FGFR3-related skeletal dysplasia in childhood.

Annals Of Pediatric Endocrinology & Metabolism
Kim, Hwa Young HY; Ko, Jung Min JM
Publication Date: 2022-06

Variant appearance in text: FGFR3: G370C
PubMed Link: 35793999
Variant Present in the following documents:
  • apem-2244114-057.pdf
View BVdb publication page



The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma.

Nature Communications
Vo, Josh N JN; Wu, Yi-Mi YM; Mishler, Jeanmarie J; Hall, Sarah S; Mannan, Rahul R; Wang, Lisha L; Ning, Yu Y; Zhou, Jin J; Hopkins, Alexander C AC; Estill, James C JC; Chan, Wallace K B WKB; Yesil, Jennifer J; Cao, Xuhong X; Rao, Arvind A; Tsodikov, Alexander A; Talpaz, Moshe M; Cole, Craig E CE; Ye, Jing C JC; , ; Bergsagel, P Leif PL; Auclair, Daniel D; Cho, Hearn Jay HJ; Robinson, Dan R DR; Chinnaiyan, Arul M AM
Publication Date: 2022-06-29

Variant appearance in text: FGFR3: 1108G>T; Gly370Cys; rs121913479
PubMed Link: 35768438
Variant Present in the following documents:
  • 41467_2022_31430_MOESM4_ESM.xlsx, sheet 1
View BVdb publication page



PD-L1 expression and FGFR-mutations among Danish patients diagnosed with metastatic urothelial carcinoma: A retrospective and descriptive study.

Apmis : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
Grantzau, Trine T; Toft, Birgitte Grønkaer BG; Melchior, Linea Cecilie LC; Elversang, Johanna J; Stormoen, Dag Rune DR; Omland, Lise Høj LH; Pappot, Helle H
Publication Date: 2022-08

Variant appearance in text: FGFR3: G370C
PubMed Link: 35616216
Variant Present in the following documents:
  • Main text
  • APM-130-498.pdf
View BVdb publication page



Fibroblast Growth Factor Receptor 1-4 Genetic Aberrations as Clinically Relevant Biomarkers in Squamous Cell Lung Cancer.

Frontiers In Oncology
Moes-Sosnowska, Joanna J; Chorostowska-Wynimko, Joanna J
Publication Date: 2022

Variant appearance in text: FGFR3: 1108G>T; G370C
PubMed Link: 35402233
Variant Present in the following documents:
  • Main text
  • fonc-12-780650.pdf
View BVdb publication page



Fibroblast growth factor receptor 3 gene (FGFR3) mutations in high-grade muscle-invasive urothelial bladder cancer in a Brazilian population: evaluation and prevalence.

Einstein (Sao Paulo, Brazil)
Monteiro, Camila Ribeiro de Arruda CRA; Korkes, Fernando F; Krutman-Zveibil, Deborah D; Glina, Sidney S
Publication Date: 2022

Variant appearance in text: FGFR3: 1108G>T; G370C
PubMed Link: 35384983
Variant Present in the following documents:
  • Main text
  • 2317-6385-eins-20-eAO6450.pdf
View BVdb publication page



FGFR2/3 genomic alterations and response to Enfortumab Vedotin in metastatic urothelial carcinoma.

Bjui Compass
Adib, Elio E; El Zarif, Talal T; Jain, Rohit K RK; Skelton, William P WP; Freeman, Dory D; Curran, Catherine C; Akl, Elie E; Nassar, Amin H AH; Ravi, Praful P; Mantia, Charlene C; Kwiatkowski, David J DJ; Choueiri, Toni K TK; Sonpavde, Guru G
Publication Date: 2022-03

Variant appearance in text: FGFR3: G370C
PubMed Link: 35224552
Variant Present in the following documents:
  • Main text
  • BCO2-3-169.pdf
View BVdb publication page



The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology.

Nature Cancer
Tamborero, David D; Dienstmann, Rodrigo R; Rachid, Maan Haj MH; Boekel, Jorrit J; Lopez-Fernandez, Adria A; Jonsson, Markus M; Razzak, Ali A; Braña, Irene I; De Petris, Luigi L; Yachnin, Jeffrey J; Baird, Richard D RD; Loriot, Yohann Y; Massard, Christophe C; Martin-Romano, Patricia P; Opdam, Frans F; Schlenk, Richard F RF; Vernieri, Claudio C; Masucci, Michele M; Villalobos, Xenia X; Chavarria, Elena E; , ; Balmaña, Judith J; Apolone, Giovanni G; Caldas, Carlos C; Bergh, Jonas J; Ernberg, Ingemar I; Fröhling, Stefan S; Garralda, Elena E; Karlsson, Claes C; Tabernero, Josep J; Voest, Emile E; Rodon, Jordi J; Lehtiö, Janne J
Publication Date: 2022-02

Variant appearance in text: FGFR3: Gly370Cys
PubMed Link: 35221333
Variant Present in the following documents:
  • 43018_2022_332_MOESM3_ESM.xlsx, sheet 1
View BVdb publication page



Fibroblast growth factor receptor signalling dysregulation and targeting in breast cancer.

Open Biology
Francavilla, Chiara C; O'Brien, Ciara S CS
Publication Date: 2022-02

Variant appearance in text: FGFR3: G370C
PubMed Link: 35193394
Variant Present in the following documents:
  • Main text
  • rsob.210373.pdf
View BVdb publication page



Tumor-Associated Mast Cells in Urothelial Bladder Cancer: Optimizing Immuno-Oncology.

Biomedicines
Choi, Hae Woong HW; Naskar, Manisha M; Seo, Ho Kyung HK; Lee, Hye Won HW
Publication Date: 2021-10-20

Variant appearance in text: FGFR3: G370C
PubMed Link: 34829729
Variant Present in the following documents:
  • Main text
  • biomedicines-09-01500.pdf
View BVdb publication page



Therapeutic Actionability of Circulating Cell-Free DNA Alterations in Carcinoma of Unknown Primary.

Jco Precision Oncology
Kato, Shumei S; Weipert, Caroline C; Gumas, Sophia S; Okamura, Ryosuke R; Lee, Suzanna S; Sicklick, Jason K JK; Saam, Jennifer J; Kurzrock, Razelle R
Publication Date: 2021

Variant appearance in text: FGFR3: G370C
PubMed Link: 34778692
Variant Present in the following documents:
  • po-5-po.21.00011.pdf
View BVdb publication page



Therapeutic Actionability of Circulating Cell-Free DNA Alterations in Carcinoma of Unknown Primary.

Jco Precision Oncology
Kato, Shumei S; Weipert, Caroline C; Gumas, Sophia S; Okamura, Ryosuke R; Lee, Suzanna S; Sicklick, Jason K JK; Saam, Jennifer J; Kurzrock, Razelle R
Publication Date: 2021

Variant appearance in text: FGFR3: G370C
PubMed Link: 34778692
Variant Present in the following documents:
  • po-5-po.21.00011.pdf
View BVdb publication page



Targetable Pathways in Advanced Bladder Cancer: FGFR Signaling.

Cancers
Xiao, Jin-Fen JF; Caliri, Andrew W AW; Duex, Jason E JE; Theodorescu, Dan D
Publication Date: 2021-09-29

Variant appearance in text: FGFR3: G370C
PubMed Link: 34638374
Variant Present in the following documents:
  • Main text
View BVdb publication page



Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.

Frontiers In Endocrinology
Hescheler, Daniel A DA; Riemann, Burkhard B; Hartmann, Milan J M MJM; Michel, Maximilian M; Faust, Michael M; Bruns, Christiane J CJ; Alakus, Hakan H; Chiapponi, Costanza C
Publication Date: 2021

Variant appearance in text: FGFR3: G370C
PubMed Link: 34630336
Variant Present in the following documents:
  • Table_1.xlsx, sheet 2
View BVdb publication page



Metastatic Urothelial Cancer: a rapidly changing treatment landscape.

Therapeutic Advances In Medical Oncology
Stecca, Carlos C; Abdeljalil, Osama O; Sridhar, Srikala S SS
Publication Date: 2021

Variant appearance in text: FGFR3: G370C
PubMed Link: 34616491
Variant Present in the following documents:
  • Main text
  • 10.1177_17588359211047352.pdf
View BVdb publication page



Fibroblast Growth Factor Inhibitors for Treating Locally Advanced/Metastatic Bladder Urothelial Carcinomas via Dual Targeting of Tumor-Specific Oncogenic Signaling and the Tumor Immune Microenvironment.

International Journal Of Molecular Sciences
Lee, Hye Won HW; Seo, Ho Kyung HK
Publication Date: 2021-09-02

Variant appearance in text: FGFR3: G370C
PubMed Link: 34502435
Variant Present in the following documents:
  • Main text
View BVdb publication page



Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinoma.

Npj Precision Oncology
Bitzer, Michael M; Spahn, Stephan S; Babaei, Sepideh S; Horger, Marius M; Singer, Stephan S; Schulze-Osthoff, Klaus K; Missios, Pavlos P; Gatidis, Sergios S; Nann, Dominik D; Mattern, Sven S; Scheble, Veit V; Nikolaou, Konstantin K; Armeanu-Ebinger, Sorin S; Schulze, Martin M; Schroeder, Christopher C; Biskup, Saskia S; Beha, Janina J; Claassen, Manfred M; Ruhm, Kristina K; Poso, Antti A; Malek, Nisar P NP
Publication Date: 2021-09-03

Variant appearance in text: FGFR3: G370C
PubMed Link: 34480077
Variant Present in the following documents:
  • Main text
  • 41698_2021_Article_220.pdf
View BVdb publication page



Comprehensive functional evaluation of variants of fibroblast growth factor receptor genes in cancer.

Npj Precision Oncology
Nakamura, Ikuko Takeda IT; Kohsaka, Shinji S; Ikegami, Masachika M; Ikeuchi, Hiroshi H; Ueno, Toshihide T; Li, Kunhua K; Beyett, Tyler S TS; Koyama, Takafumi T; Shimizu, Toshio T; Yamamoto, Noboru N; Takahashi, Fumiyuki F; Takahashi, Kazuhisa K; Eck, Michael J MJ; Mano, Hiroyuki H
Publication Date: 2021-07-16

Variant appearance in text: FGFR3: G370C
PubMed Link: 34272467
Variant Present in the following documents:
  • Main text
  • 41698_2021_204_MOESM5_ESM.xlsx, sheet 1
  • 41698_2021_Article_204.pdf
View BVdb publication page



Should We Stop Calling Thanatophoric Dysplasia a Lethal Condition? A Case Report of a Long-Term Survivor.

Palliative Medicine Reports
Carroll, Ricki S RS; Duker, Angela L AL; Schelhaas, Andrea J AJ; Little, Mary Ellen ME; Miller, Elissa G EG; Bober, Michael B MB
Publication Date: 2020

Variant appearance in text: FGFR3: G370C
PubMed Link: 34223453
Variant Present in the following documents:
  • Main text
  • pmr.2020.0016.pdf
View BVdb publication page



Insights of fibroblast growth factor receptor 3 aberrations in pan-cancer and their roles in potential clinical treatment.

Aging
Li, Juanni J; Hu, Kuan K; Huang, Jinzhou J; Zhou, Lei L; Yan, Yuanliang Y; Xu, Zhijie Z
Publication Date: 2021-06-23

Variant appearance in text: FGFR3: G370C
PubMed Link: 34160364
Variant Present in the following documents:
  • Main text
  • aging-13-203175-s003.xlsx, sheet 1
View BVdb publication page



Distinctive morphological and molecular features of urothelial carcinoma with an inverted growth pattern.

Journal Of Pathology And Translational Medicine
Sanguedolce, Francesca F; Calò, Beppe B; Chirico, Marco M; Falagario, Ugo U; Busetto, Gian Maria GM; Zanelli, Magda M; Bisagni, Alessandra A; Zizzo, Maurizio M; Ascani, Stefano S; Carrieri, Giuseppe G; Cormio, Luigi L
Publication Date: 2021-07

Variant appearance in text: FGFR3: G370C
PubMed Link: 34111910
Variant Present in the following documents:
  • Main text
  • jptm-2021-04-20.pdf
View BVdb publication page



Emerging agents for the treatment of metastatic urothelial cancer.

Investigative And Clinical Urology
Kwon, Whi An WA; Seo, Ho Kyung HK
Publication Date: 2021-05

Variant appearance in text: FGFR3: G370C
PubMed Link: 33943047
Variant Present in the following documents:
  • Main text
View BVdb publication page



Targeting FGFR in non-small cell lung cancer: implications from the landscape of clinically actionable aberrations of FGFR kinases.

Cancer Biology & Medicine
Zhou, Zhen Z; Liu, Zichuan Z; Ou, Qiuxiang Q; Wu, Xue X; Wang, Xiaonan X; Shao, Yang Y; Liu, Hongyan H; Yang, Yu Y
Publication Date: 2021-03-12

Variant appearance in text: FGFR3: G370C
PubMed Link: 33710807
Variant Present in the following documents:
  • Main text
  • cbm-18-490-s001.pdf
  • cbm-18-490.pdf
View BVdb publication page



Mutation profile and immunoscore signature in thymic carcinomas: An exploratory study and review of the literature.

Thoracic Cancer
Asselta, Rosanna R; Di Tommaso, Luca L; Perrino, Matteo M; Destro, Annarita A; Giordano, Laura L; Cardamone, Giulia G; Rubino, Luca L; Santoro, Armando A; Duga, Stefano S; Zucali, Paolo Andrea PA
Publication Date: 2021-05

Variant appearance in text: FGFR3: 1108G>T; G370C
PubMed Link: 33704917
Variant Present in the following documents:
  • TCA-12-1271-s003.xls, sheet 1
View BVdb publication page



Clinicopathologic and Genomic Characterization of PD-L1 Positive Urothelial Carcinomas.

The Oncologist
Huang, Richard S P RSP; Haberberger, James J; Harries, Lukas L; Severson, Eric E; Duncan, Daniel L DL; Ferguson, N Lynn NL; Hemmerich, Amanda A; Edgerly, Claire C; Murugesan, Karthikeyan K; Xiao, Jinpeng J; McEwan, Deborah D; Holmes, Oliver O; Hiemenz, Matthew M; Venstrom, Jeffrey J; Elvin, Julia A JA; Creeden, James J; Lin, Douglas I DI; Ross, Jeffrey S JS; Ramkissoon, Shakti H SH
Publication Date: 2021-05

Variant appearance in text: FGFR3: 1108G>T; G370C
PubMed Link: 33687775
Variant Present in the following documents:
  • Main text
View BVdb publication page



Inhibition of FGF-FGFR and VEGF-VEGFR signalling in cancer treatment.

Cell Proliferation
Liu, Guihong G; Chen, Tao T; Ding, Zhenyu Z; Wang, Yang Y; Wei, Yuquan Y; Wei, Xiawei X
Publication Date: 2021-04

Variant appearance in text: FGFR3: G370C
PubMed Link: 33655556
Variant Present in the following documents:
  • Main text
  • CPR-54-e13009.pdf
View BVdb publication page



Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer.

Cells
Sobhani, Navid N; Fassl, Anne A; Mondani, Giuseppina G; Generali, Daniele D; Otto, Tobias T
Publication Date: 2021-02-01

Variant appearance in text: FGFR3: G370C
PubMed Link: 33535617
Variant Present in the following documents:
  • Main text
  • cells-10-00293.pdf
View BVdb publication page



Typical achondroplasia secondary to a unique insertional variant of FGFR3 with in vitro demonstration of its effect on FGFR3 function.

American Journal Of Medical Genetics. Part A
Meyer, April N AN; Modaff, Peggy P; Wang, Clark G CG; Wohler, Elizabeth E; Sobreira, Nara L NL; Donoghue, Daniel J DJ; Pauli, Richard M RM
Publication Date: 2021-03

Variant appearance in text: FGFR3: Gly370Cys
PubMed Link: 33368972
Variant Present in the following documents:
  • Main text
View BVdb publication page



Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance.

British Journal Of Cancer
Krook, Melanie A MA; Reeser, Julie W JW; Ernst, Gabrielle G; Barker, Hannah H; Wilberding, Max M; Li, Gary G; Chen, Hui-Zi HZ; Roychowdhury, Sameek S
Publication Date: 2021-03

Variant appearance in text: FGFR3: G370C
PubMed Link: 33268819
Variant Present in the following documents:
  • 41416_2020_Article_1157.pdf
View BVdb publication page



Prevalence and types of inconsistencies in clinical pharmacogenetic recommendations among major U.S. sources.

Npj Genomic Medicine
Shugg, Tyler T; Pasternak, Amy L AL; London, Bianca B; Luzum, Jasmine A JA
Publication Date: 2020

Variant appearance in text: FGFR3: G370C
PubMed Link: 33145028
Variant Present in the following documents:
  • 41525_2020_156_MOESM2_ESM.xlsx, sheet 2
  • 41525_2020_156_MOESM2_ESM.xlsx, sheet 3
  • 41525_2020_156_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page